Literature DB >> 21761437

Acquired factor V inhibitor complicating warfarin therapy.

Benjamin Gartrell1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21761437     DOI： 10.1002/ajh.22073

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  3 in total

1.  Acquired factor v inhibitor developing after treatment with dabigatran etexilate methanesulfonate: a case report and review of the literature.

Authors:  Yasunobu Sekiguchi; Hitomi Yoshikawa; Asami Shimada; Hidenori Imai; Mutsumi Wakabayashi; Keiji Sugimoto; Noriko Nakamura; Tomohiro Sawada; Tetsuo Ichinose; Dai Ozaki; Norio Komatsu; Masaaki Noguchi
Journal:  Indian J Hematol Blood Transfus       Date:  2014-03-06       Impact factor: 0.900

2.  Acquired Factor V Inhibitors in a Patient with End-stage Renal Disease.

Authors:  Atsushi Kitazawa; Hideo Misawa; Katsuhiro Nagahori; Ryo Koda; Atsunori Yoshino; Shinya Kawamoto; Tetsuro Takeda
Journal:  Intern Med       Date:  2016-12-01       Impact factor: 1.271

3.  Acquired factor V inhibitor in a patient with mantle cell lymphoma presenting with hematuria followed by thrombosis: a case report.

Authors:  Naif I Aljohani; John H Matthews
Journal:  Int Med Case Rep J       Date:  2014-02-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.